Golimumab

What is Golimumab?

Golimumab is an antipsoriatic, antirheumatic monoclonal antibody. It is used for the treatment of active rheumatoid arthritis (moderate-to-severe), active psoriatic arthritis, and active ankylosing spondylitis.

Save up to 80% off your prescriptions!

How do members experience Golimumab?

Top 5 reported purposes & perceived effectiveness

Purpose Patients Evaluations Perceived Effectiveness
Rheumatoid arthritis 714 29
Ulcerative colitis 27 4
Psoriasis 23 2
Psoriatic arthritis 16 9
Ankylosing spondylitis 14 11

Common side effects

Side effect Patients Percentage
Fatigue 4
Hair loss 2
Psoriasis 2
Bruising 1
Elevated liver enzymes 1
Hair thinning 1

Side effect severity

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 8
Mild 14
None 28

Member evaluations

c

caela

evaluated on May 23, 2021

  • Perceived effectiveness for ankylosing spondylitis: Major
  • Side effects: None

25yrRA

evaluated on Mar 15, 2016

  • Perceived effectiveness for rheumatoid arthritis: Slight
  • Side effects: Mild

Firerose

evaluated on Apr 15, 2014

  • Perceived effectiveness for rheumatoid arthritis: Moderate
  • Side effects: None
Learn more about our community’s experience with Golimumab

What are people saying about Golimumab?

967

967

members have reported taking Golimumab

Join the conversation and connect with people who have taken Golimumab
Treatment Options for Ulcerative Colitis (UC)
Last updated:

Save up to 80% off your prescriptions!

ADVERTISEMENT

ADVERTISEMENT